Searched for
VIRCHOW BIOTECH
Local drug companies in a fix over Sputnik amid sanctions against RDIFRDIF is commercialising the Sputnik vaccine globally, which was developed by Russia's Gamaleya Research Institute.- Russian fund seeks Sputnik M registration for adolescentsIn April 2021, India had granted an emergency use authorisation for Sputnik V. RDIF said its Sputnik V has been authorised in 71 countries ...
- Wockhardt, Enso Health join hands for Sputnik jabsDrug maker Wockhardt said on Friday that it partnered with Enso Healthcare, an aggregator for Russian Direct Investment Fund (RDIF) for its...
- Serum Institute to begin manufacturing Sputnik V from SeptemberWith their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun, RDIF, which is promoting the ...
- Serum Institute to start production of Sputnik vaccine in India in SeptemberAs per the agreement between RDIF and SII, the parties intend to produce over 300 million doses of the vaccine in India per year.
- Hetero begins Sputnik V production at Hyderabad facilityIn an interaction with the Russian president Vladimir Putin on Friday through a video conference, Hetero group’s Chairman Dr Bandi Parthasa...
- Serum Institute gets approval to manufacture Russia’s Sputnik VSII had applied to the Drug Controller General of India (DCGI) seeking permission for a test licence to manufacture Sputnik V, which is bei...
- Hetero Biopharma gets nod for Sputnik phase-3 trialsThe RDIF has signed agreements with several companies to manufacture Sputnik V in India — Virchow Biotech (up to 200 million doses per year...
- Indian makers of Sputnik V may seek waiver for local Phase-3 trialsOne of the six, Hetero Biopharma, had last fortnight obtained clearance from the subject expert committee under India’s drug controller to ...
- Private hospitals to offer Sputnik V soonPrivate hospitals are likely to introduce the vaccine for those in the 18-44 age group by next week. However, state governments won’t have ...
- Dr Reddy’s announces soft launch of Sputnik V in India, imported doses priced at Rs 948 and 5% GSTSputnik V was developed by Russia’s Gamaleya National Research Institute of Epidemiology and Microbiology with the backing of Russia’s sove...
- India to produce 850 mn Sputnik V doses annually, says Russia's sovereign wealth fundThe vaccine has been approved for use in countries with a total population of 3 billion people or about 40 per cent of the global populatio...
- Russia's Sputnik gets India nod, Dr Reddy’s can now import and sell itThe Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) on Monday took up the application of Dr Reddy...
- Sputnik V emergency use authorisation likely soon: Russian Deputy envoy to IndiaRoman Babushkin said that the approval for emergency use is 'anticipated very much' within 7-10 days and said the vaccine can be stored bet...
- Covid-19: More Indian cos could begin manufacturing Sputnik vaccineIt is indicative that companies like Serum Institute of India (SII), Panacea Biotec and Biocon may also get into manufacturing Sputnik, not...
- How India can target 5 million vaccinations a dayWith debilitating lockdowns no longer an option, India needs to more than double daily vaccinations to curb the second wave and get the cou...
- More local companies to produce vaccines as demand soarsWhile Serum Institute manufactures the Oxford-AstraZeneca vaccine, most of the other deals for contract manufacturing have come from the Ru...
- IPAB's verdict on Roche's Hepatitis C drug patent may impact MerckThe IPAB revoked Roche's patent for Pegasys on grounds that the process of pegylation did not enhance the efficacy of the drug.
- Ranbaxy launches Bio-generic injectable for OsteoporosisRanbaxy Laboratories Ltd on Thursday announced the launch of 'BONISTA- Teriparatide' injection used in the treatment of Osteoporosis diseas...
- Ranbaxy Labs launches Bonista-Teriparatide injection for OsteoporosisRanbaxy Laboratories has launched Bonista-Teriparatide injection for the treatment of Osteoporosis, in collaboration with Virchow Biotech, ...
Load More
